- Home
- CRDL vs YOUL Comparison
CRDL vs YOUL Comparison
Compare CRDL & YOUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRDL | YOUL |
|---|---|---|
| Founded | 2017 | N/A |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 107.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRDL | YOUL |
|---|---|---|
| Price | $1.07 | $1.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 373.9K | N/A |
| Earning Date | 03-30-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | N/A |
| 52 Week High | $1.59 | N/A |
Technical Indicators
Market Signals| Indicator | CRDL | YOUL |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 45.01 |
| Support Level | $0.95 | $1.09 |
| Resistance Level | $1.04 | $1.31 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 76.47 | 16.16 |
Price Performance
Historical ComparisonAbout CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About YOUL Youlife Group Inc. American Depositary Shares
Youlife Group Inc is a blue-collar lifetime service provider with a nationwide network of 25 vocational schools under school management model and 25 curriculum development projects, covering a total of 37 cities or counties under 16 provinces of China.